Staging of Breast Phyllodes Tumors
Phyllodes tumors of the breast are NOT staged using the TNM classification system. 1
Key Distinction from Breast Carcinoma
Phyllodes tumors are fibroepithelial neoplasms with stromal and epithelial elements that behave fundamentally differently from epithelial breast cancers. 1 The standard TNM staging system used for breast carcinomas does not apply to these tumors because:
- Axillary lymph node metastases are exceedingly rare, making the "N" component of TNM irrelevant 1, 2
- Metastatic spread occurs hematogenously (primarily to lungs) rather than through lymphatic channels 1, 2
- Surgical axillary staging or lymph node dissection is not necessary unless nodes are clinically pathologic on examination 1
Classification System Used
Instead of TNM staging, phyllodes tumors are classified histologically into three subtypes: 1
- Benign
- Borderline
- Malignant
This histologic classification is based on multiple parameters including stromal hypercellularity, atypia, mitotic count, stromal overgrowth, and tumor borders. 3
Important Clinical Caveat
The histologic subtype (benign vs. borderline vs. malignant) is less predictive of recurrence risk than achieving adequate surgical margins. 1 The margin width achieved during surgical resection is the most critical prognostic factor, with margins ≥1 cm recommended for all subtypes. 1
Management of Metastatic Disease
When systemic metastases occur (typically pulmonary), phyllodes tumors should be managed according to soft tissue sarcoma protocols, not breast cancer staging or treatment algorithms. 2 This reflects their mesenchymal (stromal) nature rather than epithelial origin. 2